Pregledni rad
Vasoactive Agents
Ino Husedzinovic
; Department for anesthesiology, reanimatology and intensive care medicine; University Hospital Dubrava; Gojko Susak Avenue No 6; 10000 Zagreb, Croatia
Nikola Bradic
; Department for anesthesiology, reanimatology and intensive care medicine; University Hospital Dubrava; Gojko Susak Avenue No 6; 10000 Zagreb, Croatia
Tanja Goranovic
; Department for anesthesiology, reanimatology and intensive care medicine; University Hospital Dubrava; Gojko Susak Avenue No 6; 10000 Zagreb, Croatia
Sažetak
This article is a short review of vasoactive drugs which are in use in todays clinical practice. In the past century, development of vasoactive drugs went through several phases. All of these drugs are today divided into several groups, depending on their place of action, pharmacological pathways and/or effects on target organ or organ system. Hence, many different agents are today in clinical practice, we have shown comparison between them. These agents provide new directions in the treatment of cardiovascular compromise, suggesting that the primary goal of therapy is to produce a vasodilatory effect of the circulation rather than to reverse hemodynamic failure by using inotropic agents, with their inherent risks and side effects.
Ključne riječi
vasoactive agents; inotropic agents; levosimendan; phosphodiesterase III inhibitors
Hrčak ID:
11955
URI
Datum izdavanja:
1.10.2006.
Posjeta: 2.989 *